Patent · US Active

(heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors

US8906924B2 · kind B2 · utility

1Cited by

7References

6Claims

0Family size

Assignee

Sanofi · FR

Inventors

Marco Baroni · Mantova, IT
Francoise Bono · Paris, FR
Sandrine Delbary-Gossart · Mauzac, FR
Valentina Vercesi · Pavia, IT

Key dates

Filing date	Jul 18, 2013
Grant date	Dec 9, 2014
Priority date	—
Expiry date	Jul 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I):wherein A, B, m, n, W, and R2 are as defined in the disclosure; to the methods of preparing said derivatives, and to the therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.